RhG-CSF improves radiation-induced myelosuppression and survival in the canine exposed to fission neutron irradiation

Journal of Radiation Research

Volumn 52, Issue 4, 2011, Pages 472-480

  Yu, Zu Yin ^a   Li, Ming ^a   Han, A Ru Na ^a   Xing, Shuang ^a   Ou, Hong Ling ^a   Xiong, Guo Lin ^a   Xie, Ling ^a   Zhao, Yan Fang ^a   Xiao, He ^b   Shan, Ya Jun ^a   Zhao, Zhen Hu ^a   Liu, Xiao Lan ^a   Cong, Yu Wen ^a   Luo, Qing Liang ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^b Department of Pharmacology   (China)

Author keywords

Myelosuppression; Neutron irradiation; RhG CSF

Indexed keywords

FISSION REACTIONS; NEUTRONS; RADIATION DAMAGE;

EXPOSED TO; FISSION NEUTRONS; HAEMATOPOIETIC SYSTEMS; LEUCOPENIA; MYELOSUPPRESSION; NEUTRON RADIATIONS; NEUTROPENIA; RADIATION-INDUCED; RECOMBINANT HUMAN GRANULOCYTE COLONY STIMULATING FACTORS; RHG-CSF;

NEUTRON IRRADIATION;

CANIS FAMILIARIS;

EID: 79960866460     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1269/jrr.10103     Document Type: Article

References (32)

1. Ainsworth EJ, et al (1965) Comparative lethality responses of neutron and x irradiated dogs: Influence of dose rate and exposure aspect. Radiat Res 26: 32-43.
2. Alpen EL, Shill OS and Tochilin E (1960) The effects of total body irradiation of dogs with simulated fission neutrons. Radiat Res 12: 237-250.
3. Broerse JJ, et al (1978) Mortality of monkeys after exposure to fission neutrons and the effect of autologous bone marrow transplantation. Int J Radiat Biol 34: 253-264.
4. MacVittie TJ, et al (1990) The relative biological effectiveness of mixed fission neutron-radiation on the hematopoietic syndrome in the canine: Effect of therapy on survival. Radiat Res 128: S29-S36.
5. Wang J, et al (1991) The response of dogs to mixed neutron-γ radiation with different n/γ ratio. Radiat Res 128: S42-S46.
6. Randolph ML, et al (1957) Effect of bone marrow treatment on mortality of mice irradiated with fast neutrons. Science 125: 1083-1084.
7. Alpen EL and Baum SJ (1959) Autologous bone-marrow implantation after fast neutron irradiation of dogs. Radiat Res 11: 383-389.
8. Davids JAG (1970) Bone-marrow syndrome in CBA mice exposed to fast neutrons of 1.0 MeV mean energy. Effect of syngeneic bone-marrow transplantation. Int J Radiat Biol 17: 173-185.
9. Wang J and Zhang SY (1983) Protective effect of WR-2721 on the mice exposed to n-γ mixed irradiation of different ratio. Chin J Radiol Med Prot 3: 12-14. (in Chinese)
10. Wang J and Wang BQ (2001) Acute neutron-irradiation sickness. In: Mao BZ and Chen JP eds. Basical and Clinical Acute Radiation Sickness. pp. 199-235. Military Medical Science Publishing Group; Beijing. (in Chinese)
11. Farese AM, et al (1993) Combination protocols of cytokine therapy with interleukin-3 and granulocyte-macrophage colony-stimulating factor in a primate model of radiation-induced marrow aplasia. Blood 82: 3012-3018.
12. MacVittie TJ, et al (1994) Therapeutic efficacy of recombinant interleukin-6 alone and combined with recombinant human interleukin-3 in a nonhuman primate model of high-dose, sublethal, radiation-induced marrow aplasia. Blood 84: 2515-2522.
13. Farese AM, Myers LA and MacVittie TJ (1994) Therapeutic efficacy of recombinant human leukemia inhibitory factor in a primate model of radiation-induced marrow aplasia. Blood 84: 3675-3678.
14. Waselenko JK, et al (2004) Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group. Ann Intern Med 140: 1037-1051.
15. Tanikawa S, et al (1990) Effects of recombinant human granuloctye colonystimulating factor on the hematologic recovery and survival of irradiated mice. Blood 76: 445-449.
16. Sureda A, et al (1993) A single dose of granulocyte colony stimulating factor modifies radiation-induced death in B6D2F1 mice. Exp Hematol 21: 1605-1607.
17. Schuening FG, et al (1989) Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis of normal dogs and on hematopoietic recovery after otherwise lethal total body irradiation. Blood 74: 1308-1313.
18. MacVittie TJ, et al (1990) Therapeutic use of recombinant human G-CSF (rhG-CSF) in a canine model of sublethal and lethal whole-body irradiation. Int J Radiat Biol 57: 723-736.
19. MacVittie TJ, Farese AM and Jackson III W (2005) Defining the full therapeutic potential of recombinant growth factors in the post radiation-accident environment: the effect of supportive care plus administration of G-CSF. Health Phys 89: 546-555.
20. MacVittie TJ, et al (1996) Combination therapy for radiation-induced bone marrow aplasia in nonhuman primates using synthokine SC-55494 and recombinant human granulocyte colony-stimulating factor. Blood 87: 4129-4135.
21. Hao J, et al (2004) Effects of recombinant human interleukin 11 on thrombocytopenia and neutropenia in irradiated rhesus monkeys. Radiat Res 162: 157-163.
22. D'Onofrio G, et al (1996) Indicators of haematopoietic recovery after bone marrow transplantation: the role of reticulocyte measurements. Clin Lab Haematol 18: 45-53.
23. Kudo T, et al (2008) Recombinant human granulocyte colony-stimulating factor reduces colonic epithelial cell apoptosis and ameliorates murine dextran sulfate sodium-induced colitis. Scand J Gastroenterol 43: 689-697.
24. Canpolat FE, et al (2006) Protective effects of recombinant human granulocyte colony stimulating factor in a rat model of necrotizing enterocolitis. Pediatr Surg Int 22: 719-723.
25. Atasoy Beste M, et al (2008) Granulocyte colony stimulating factor ameliorates radiation-induced morphological destruction of intestinal mucosa in rats. Marmara Med J 21: 1-6.
26. Egi H, et al (2003) Regulation of T helper type-1 immunity in hapten-induced colitis by host pretreatment with granulocyte colony-stimulating factor. Cytokine 23: 23-30.
27. Li M, et al (2010) Effect of rhG-CSF on blood coagulation in beagles irradiated by 2.3 Gy neutron. Zhongguo Shi Yan Xue Ye Xue Za Zhi 18: 1520-1524. (in Chinese)
28. LeBlanc R, et al (1999) A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors. Bone Marrow Transplant 23: 991-996.
29. Falanga A, et al (1999) Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony-stimulating factor. Blood 93: 2506-2514.
30. Topcuoglu P, et al (2004) Administration of granulocyte-colony-stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor-dependent pathway in healthy donors. Bone Marrow Transplant 33: 171-176.
31. Shimoda K, et al (1993) Granumlocyte colony-stimulating factor and platelet aggregation. Lancet 341: 633.
32. Spiel AO, et al (2010) Single dose granulocyte colony-stimulating factor markedly enhances shear-dependent platelet function in humans. Platelets 21: 464-469.